ARTICLE | Company News
Micrologix, Strata Pharmaceuticals Inc. deal
August 9, 2004 7:00 AM UTC
MBI granted to Strata exclusive European and North American development and marketing rights to MBI-226, a topical antimicrobial cationic peptide, to prevent catheter-related infections. MBI will rece...